Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist series.
Bioorg Med Chem Lett
; 25(15): 3034-8, 2015 Aug 01.
Article
em En
| MEDLINE
| ID: mdl-26048791
ABSTRACT
The design and optimization of a novel trans-1,4-dioxycyclohexane GPR119 agonist series is described. A lead compound 21 was found to be a potent and efficacious GPR119 agonist across species, and possessed overall favorable pharmaceutical properties. Compound 21 demonstrated robust acute and chronic regulatory effects on glycemic parameters in the diabetic or non-diabetic rodent models.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cicloexanos
/
Receptores Acoplados a Proteínas G
/
Diabetes Mellitus Tipo 2
/
Hipoglicemiantes
Limite:
Animals
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article